Debt and Credit Facilities - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended	9 Months Ended				3 Months Ended	9 Months Ended		1 Months Ended	9 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Aug. 29, 2014 Delayed Draw Term Loan A Facility [Member]	Sep. 30, 2014 Line of Credit Secured Debt	Sep. 30, 2014 Line of Credit Secured Debt	Sep. 30, 2014 Line Of Credit Facility Second Amended	Jul. 25, 2014 Line Of Credit Facility Second Amended Term Loan A Facility [Member]	Sep. 30, 2014 Line Of Credit Facility Second Amended Term Loan A Facility [Member]	Jul. 25, 2014 Line Of Credit Facility Second Amended Delayed Draw Term Loan A Facility [Member]	Sep. 30, 2014 Line Of Credit Facility Second Amended Term Loan B Facility Noncurrent [Member]	Jul. 25, 2014 Line Of Credit Facility Second Amended Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Aggregate principal amount					$ 100				$ 1,330		$ 100
Credit facility agreement date								Jul. 25, 2014
Amount outstanding under revolving credit facility	276.0	276.0		0									700.0
Decrease in interest margin									0.75%
Credit facility, maturity date										Jul. 25, 2019
Credit facility, description								(i) the refinancing of the term loan A facilities, term loan B facilities and revolving credit facilities with new term loan A facilities (including facilities in Canadian dollars, euros, Japanese yen, pounds sterling and U.S. dollars) in an aggregate principal amount equivalent to $1,330 million and revolving credit facilities of $700 million, (ii) a new $100 million delayed draw term loan A facility (used for our Brazilian operations), (iii) a 0.75% reduction of the interest rate margin for the term loan A facilities and revolving credit facilities, (iv) extension of the final maturity of the term loan A facilities and revolving credit commitment to July 25, 2019, (v) adjustments to the financial maintenance covenant of Consolidated Net Debt to Consolidated EBITDA (as defined in the Second Amended and Restated Credit Agreement) and other covenants to provide additional flexibility to the Company and (vi) other amendments.
Amortization expenses related to the debt instruments						2	9					13
Notional amount of outstanding interest rate swaps	100	100		100	100
Loss on debt redemption and refinancing activities	(17.7)	(18.5)	(32.4)					(18.0)
Non-lender fees		5						5
Lender fees		$ 2